the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

View All Categories
View Conferences

Infection Disease Market Research Reports

 

Global Information, Inc. offers market intelligence on every topic in the Infection Disease Therapeutic, including, but not limited to market trend on Vaccines; Antibacterials; Antivirals; Antifungal and therapeutic of: HIV; SARS; Hepatitis B; Hepatitis C.

We offer market research, industry forecasts, and business analysis in the Infection Disease Therapeutic as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.

 
 
Systemic Fungal Infection Therapeutics Market- Taiwan
Table of Contents Published: 2009/11 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Systemic Fungal Infection Therapeutics Market - Australia
Table of Contents Published: 2009/11 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Systemic Fungal Infection Therapeutics Market - Singapore
Table of Contents Published: 2009/11 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Opportunity Analysis of H1N1 (swine flu) Vaccination Market
Table of Contents Published: 2009/11 Published by: Markets and Markets
H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009. The flu broke in Mexico in the month of March and then affected U.S. and after that ...

Antiviral Therapeutics - technologies, markets and companies
Table of Contents Published: 2009/11 Published by: Jain Pharmabiotech
This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their ...

Systemic Fungal Infection Therapeutics Market - South Korea
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Systemic Fungal Infection Therapeutics Market Research - Philippines
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Systemic Fungal Infection Therapeutics Market - Hong Kong
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Systemic Fungal Infection Therapeutics Research - Malaysia
Table of Contents Published: 2009/10 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of systemic fungal infection, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the systemic fungal infec ...

Malaria Patent Landscape 2009
Table of Contents Published: 2009/10 Published by: France Innovation Scientifique et Transfert (FIST SA)
Malaria, along with HIV and Tuberculosis, is one of the three most common infectious diseases in the world. It has infected human beings for over 50,000 years and may have been a human pathogen throughout the entire history of our species. An estimated 30 ...

HIV Therapy Patent Landscape 2009
Table of Contents Published: 2009/10 Published by: France Innovation Scientifique et Transfert (FIST SA)
The Human Immunodeficiency Virus (HIV) is a double-stranded RNA virus from the Retroviridae family. Discovered in 1983, HIV is responsible for the Acquired Immune Deficiency Syndrome (AIDS). Its mechanisms of action and transmission were described in the ...

SPECIAL REPORT: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009
Table of Contents Published: 2009/10 Published by: Decision Resources, Inc.
WHO and the European Centre for Disease Prevention and Control (ECDC) are advising countries to prepare for a more severe second wave of A/H1N1 2009 in the winter of 2009-2010. This advisement could be warranted, given that no infectious disease has kille ...

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
Table of Contents Published: 2009/10 Published by: Kalorama Information
The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is ...

Pipeline Insight: HIV - The Age of Convenience
Table of Contents Published: 2009/10 Published by: Datamonitor
Three new partnerships are reshaping the competitive environment in HIV. Most notably, Tibotec/Johnson & Johnson is linking up with Gilead to combine their Phase III drug rilpivirine with Truvada to create a new gold standard fixed dose combination for tr ...

Infectious Diseases Drugs Markets
Table of Contents Published: 2009/10 Published by: Trimark Publications
According to the World Health Organization (WHO), six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults. ...

Blood Typing, Grouping and Infectious Disease Screening Tests:Analysis of Current and Emerging Assays and Companies Developing New Technologies and Products
Table of Contents Published: 2009/09 Published by: Venture Planning Group
The report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing n ...

Health and Hygiene - Fear of Germs and Bacteria - UK - September 2009
Table of Contents Published: 2009/09 Published by: Mintel International Group Ltd,
Qualitative research run by Mintel with Toluna shows that, although people claim not to have changed their hygiene habits in the wake of the swine flu publicity, they do appear to be more aware of germs. ...

The Future of the Biodefense Industry: Regulation, funding opportunities & company profiles
Table of Contents Published: 2009/09 Published by: Business Insights
The major contemporary bioterrorist event which has opened up programs of research and development (R&D) in pharmaceutical countermeasures and treatments was the anthrax mail attacks which occurred only weeks after the 9/11 atrocities, in October 2001. ...

Seasonal Influenza Vaccines Market Forecast
Table of Contents Published: 2009/08 Published by: Datamonitor
Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivira ...

The Global Influenza Market
Table of Contents Published: 2009/08 Published by: BCC Research
Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics Offers a global analysis, with emphasis on U.S. data, and a five-year forecast period through 2014 Identifies markets in the segments of vaccines/therapeuti ...

Competitor Analysis: Targeted Therapy of Hepatitis C
Table of Contents Published: 2009/08 Published by: La Merie
The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2009. Purchase of the downloadable pdf re ...

Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
Table of Contents Published: 2009/08 Published by: Datamonitor
Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivira ...

China Vaccine Industry Report, 2008-2009
Table of Contents Published: 2009/08 Published by: ResearchInChina
Based on authoritative statistics, this report makes in-depth analysis on China vaccine industry development, vaccine market, vaccine import & export, key vaccine producers, and also forecasts the development trend of China' s vaccine industry in 2009. Va ...

Infectious Disease Diagnostic Markets
Table of Contents Published: 2009/08 Published by: Kalorama Information
This report focuses on products used for the diagnosis of bacterial and viral infections. The major consideration is given to bacterial infections because (a) they are the most frequent type of infections, and (b) the practical aspects of diagnosis and th ...

Stakeholder Opinions: Skin and Soft Tissue Infections - The end of the reign of vancomycin
Table of Contents Published: 2009/07 Published by: Datamonitor
Treatment of skin and skin structure infections often requires systemic antibacterial therapy. Two trends are concerning physicians: the spread of methicillin-resistant Staphylococcus aureus (MRSA), particularly community-acquired strains (CA-MRSA) have b ...

HIV Market Forecast
Table of Contents Published: 2009/06 Published by: Datamonitor
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiati ...

Forecast Insight: HIV - Cross-class fixed dose combinations drive continued growth
Table of Contents Published: 2009/06 Published by: Datamonitor
In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiati ...

Chinese Markets for Anti-Infectious Disease Drugs
Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co.
China' s demand for Anti-Infectious Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry dev ...

Chinese Markets for Hepatitis Treatment Drugs
Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co.
This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-te ...

European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
Table of Contents Published: 2009/06 Published by: Frost & Sullivan
This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and ch ...

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
Table of Contents Published: 2009/05 Published by: Kalorama Information
The outbreak of swine flu is highlighting the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. ...

Hepatitis C Virus And Therapeutics
Table of Contents Published: 2009/04 Published by: Global Industry Analysts, Inc.
This report analyzes the worldwide markets for Hepatitis C Virus And Therapeutics in US$ Millions. Annual forecasts are provided for each region for the period of 2006 through 2015. ...

Chinese Markets for Cold and Flu Drugs
Table of Contents Published: 2009/04 Published by: Asia Market Information & Development Co.
China' s demand for Cold and Flu Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, s ...

European HIV/AIDS Therapeutics Markets
Table of Contents Published: 2009/04 Published by: Frost & Sullivan
This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges ...

Stakeholder Opinions: Urinary Tract Infections Growing resistance rates bring opportunities for both new and old drugs
Table of Contents Published: 2009/04 Published by: Datamonitor
Urinary tract infections (UTIs) include infections of the kidneys, ureters, and bladder. Escherichia coli is the major UTI pathogen, with emerging extended-spectrum beta-lactamase (ESBL)-producing strains proving particularly difficult to treat. Bacterial ...

Who's Doing What in Molecular Diagnostics? - The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories
Table of Contents Published: 2009/04 Published by: Kalorama Information
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass o ...

Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
Table of Contents Published: 2009/03 Published by: Datamonitor
Tuberculosis is a major cause of illness and death worldwide, but despite 14.4 million prevalent cases, 9.2 million new cases and 1.7 million deaths in 2006, the small and rapidly declining burden of disease in the seven major markets has limited drug and ...

Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia
Table of Contents Published: 2009/03 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Ind ...

Opportunities Assessment for Hepatitis B Therapeutics in Thailand
Table of Contents Published: 2009/03 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Tha ...

Protease Inhibitors: Innovation Drives Drug Pipeline
Table of Contents Published: 2009/02 Published by: Insight Pharma Reports
Proteases constitute one of the largest potential drug target enzyme families, with 647 human gene products incorporating protease sequences and mutated proteases having been identified. In addition, there are many more proteases found in viruses, bacteri ...

Global HIV Market: An Analysis
Table of Contents Published: 2009/02 Published by: Koncept Analytics
In Japan, unwanted teen pregnancy is rising which may drive HIV drugs market in near future. Also the innovation of new drugs is driving HIV market; research continues to remain a significant unmet medical need for effective treatment. The report outl ...

Hepatitis C Market Forecast
Table of Contents Published: 2009/01 Published by: Datamonitor
The Hepatitis C market was worth $2.3 billion in 2007, declining at a CAGR of -2.8% from 2004-2007. Despite this recent slump, Datamonitor forecasts sales to grow to $4.5 billion by 2017, driven primarily by the launch of the new protease inhibitors. The ...

Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)
Table of Contents Published: 2009/01 Published by: Kalorama Information
A nosocomial, or hospital-acquired, infection is a new infection that is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, This type of infection is also known as a hospital-acquired infectio ...

European Point of Care (POC) Infectious Disease Market
Table of Contents Published: 2008/12 Published by: Frost & Sullivan
This research service gives a detailed analysis of the European point of care (POC) infectious disease market from 2008-2015. ...

Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In times of crisis, Big Pharma turns to vaccines
Table of Contents Published: 2008/12 Published by: Datamonitor
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price products such as Wyeth' s Prevnar or Merck & Co' s Gardasil, along with the emergence of n ...

U.S. Molecular Diagnostics Markets for Emerging Infectious Disease Tests
Table of Contents Published: 2008/12 Published by: Frost & Sullivan
This research service analyzes the market for emerging infectious disease molecular diagnostics within the United States. The United States market was divided into the HPV molecular diagnostics and MRSA molecular diagnostics market segments. ...

Study for Opportunities Assessment for Hepatitis B Therapeutics in China
Table of Contents Published: 2008/12 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of Hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the Hepatitis B therapeutics market in ...

Study for Opportunities Assessment for Hepatitis B Therapeutics in Korea
Table of Contents Published: 2008/12 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Kor ...

Study for Opportunities Assessment for Hepatitis B Therapeutics in India
Table of Contents Published: 2008/12 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of Hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Ind ...

Study for Opportunities Assessment for Hepatitis B Therapeutics in Taiwan
Table of Contents Published: 2008/12 Published by: Frost & Sullivan
This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Tai ...

Anti-Infective Drug News: Monitoring Antibiotic & Antiviral Drug Developments Worldwide
Issues / Year: 22 Published by: Espicom Business Intelligence
AIN makes tracking drug & company developments in the anti-infective area easy. ...

Autoimmune Drug Focus (ADF)
Issues / Year: 12 Published by: Espicom Business Intelligence
Do you want to keep up-to-date with all the latest developments in this important and high-value pharmaceutical area? Autoimmune Drug Focus (ADF) provides a simple, time-saving way to do just that. It summarises all the latest developments in an easy-to-r ...


US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.